Tag Archives: One-third of vaccines made for poor nations stay in India

NEW DELHI: India itself has received more than a third of the nearly 28 million Indian-made AstraZeneca Covid-19 vaccine doses delivered so far by the global programme for poor countries, according to data from Umicef and a source. The revelation that the largest allocation of doses India has supplied to the Covax programme never actually left the country could add …

Read More »